Our Services

Gastroenterology

Gut & Digestion

  • Gastroesophageal reflux disease (GERD)

  • Acid reflux / laryngopharyngeal reflux (LPR)

  • Peptic ulcer disease (gastric and duodenal ulcers)

  • Gastritis (acute, chronic, including H. pylori–associated)

  • Gastroparesis and delayed gastric emptying

  • Functional dyspepsia / non-ulcer dyspepsia

  • Erosive esophagitis and Barrett’s esophagus (surveillance support)

  • Eosinophilic esophagitis (EoE)

  • Food intolerances (lactose, FODMAP sensitivity)

  • Celiac disease and non-celiac gluten sensitivity

  • Malabsorption syndromes (fat, carbohydrate, protein, micronutrient deficiencies)

  • Pancreatic exocrine insufficiency (leading to malabsorption)

  • Medication-induced GI injury (NSAID-associated ulcers, steroid effects, other drug reactions)

Bowel Health

  • Irritable Bowel Syndrome (IBS) — IBS-C, IBS-D, IBS-Mixed

  • Inflammatory bowel disease (IBD)

    • Crohn’s disease (small bowel, colonic, perianal disease)

    • Ulcerative colitis (left-sided, pancolitis)

    • IBD-related complications (strictures, fistulae, extraintestinal manifestations)

  • Chronic constipation and pelvic floor dysfunction

  • Chronic diarrhea (infectious, inflammatory, functional causes)

  • Chronic intestinal pseudo-obstruction and severe motility disorders

  • Diverticular disease

  • Colorectal polyps and post-polypectomy surveillance support

  • Colorectal cancer surveillance and risk-factor management

  • Anal and rectal disorders (hemorrhoids, fissures, proctitis)

  • Intestinal ischemia (chronic mesenteric ischemia)

  • Post-infectious bowel dysfunction (post-infectious IBS)

  • Opportunistic/parasite infections affecting bowel health

  • Microbiome-related dysbiosis and strategies for modulation


Hepatology

Liver, Gallbladder & Pancreas

  • MASH/ NASH

    • Fibrosis and staged hepatic fibrosis (F0–F4)

      Compensated and decompensated cirrhosis, and associated symptoms

    • Viral hepatitis (hepatitis A, B, C) — prevention, monitoring, and supportive care

    • Alcohol-associated liver disease (ALD)

      • Alcoholic fatty liver

      • Alcoholic hepatitis (mild, moderate, severe)

      • Alcohol-associated cirrhosis and complications

    • Autoimmune and immune-mediated liver disease

      • Autoimmune hepatitis

      • Primary biliary cholangitis (PBC)

      • Primary sclerosing cholangitis (PSC)

      • Overlap syndromes (AIH-PBC, AIH-PSC)

      • Immunosuppressive therapies and monitoring

    • Genetic and metabolic liver diseases

      • Hemochromatosis (hereditary iron overload)

      • Wilson disease (copper metabolism)

      • Alpha-1 antitrypsin deficiency

    • Cholestatic liver diseases and biliary obstruction

    • Vascular and ischemic liver conditions

      • Budd–Chiari syndrome (hepatic vein thrombosis)

      • Portal vein thrombosis

    • Tumors and mass lesions of the liver

      • Benign lesions: hemangioma, focal nodular hyperplasia, hepatic adenoma, cysts

      • Surveillance, diagnosis, locoregional and systemic therapies

    • Drug- and toxin-induced liver injury (DILI)

      • Acute and chronic presentations

Psychiatry

Mood & Stress

  • Generalized anxiety disorder

    • Panic disorder

    • Phobic disorders (specific phobia, agoraphobia, social anxiety disorder)

    • Major depressive disorder (single episode, recurrent)

    • Persistent depressive disorder (dysthymia)

    • Bipolar spectrum disorders (bipolar I, bipolar II, cyclothymic disorder)

    • Posttraumatic stress disorder (PTSD)

    • Acute stress disorder

    • Adjustment disorders (with depressed mood, with anxiety, with mixed disturbance of emotions and conduct)

    • Trauma-related conditions (complex PTSD, developmental trauma disorder considerations)

    • Situational stress responses and burnout

    • Obsessive-compulsive disorder (OCD) and related disorders when contributing to mood/stress symptoms

    • Grief and bereavement-related depressive symptoms

    • Seasonal affective disorder (seasonal pattern depression)

    • Substance-/medication-induced mood or anxiety disorders

    • Comorbid medical-condition–related mood or anxiety presentations

    Neurodivergent & Behavioral Support

    • Attention‑deficit/hyperactivity disorder (ADHD)

    • Autism spectrum disorder (ASD), including varying levels of support needs and presentations

    • Intellectual disability (intellectual developmental disorder)

    • Specific learning disorders (e.g., dyslexia, dyscalculia, dysgraphia)

    • Developmental coordination disorder (dyspraxia)

    • Tic disorders, including Tourette’s disorder and persistent (chronic) motor or vocal tic disorder

    • Oppositional defiant disorder (ODD)

    • Conduct disorder

    • Disruptive mood dysregulation disorder (DMDD)

    • Sensory processing disorder / differences (sensory modulation challenges)

    • Sleep‑related behavioral disorders associated with neurodevelopmental conditions

    • Adaptive functioning challenges related to neurodivergence

  • Psychiatric Medication Optimization

    • Thoughtful evaluation, synergistic medication management, and deprescribing reviews when appropriate.